Clinical Outcomes
To assess the efficacy and safety of NOACs versus VKAs in patients with
AF and polypharmacy, we divided the included clinical outcomes into
primary outcomes (stroke or systemic embolism, major bleeding) and
secondary outcomes (ischemic stroke, all-cause death, any bleeding,
intracranial bleeding, gastrointestinal bleeding).